President of the New Zealand Association of Clinical Research
Meghan McIlwain is the President of the New Zealand Association of Clinical Research and a Clinical Research Manager at MSD. Originally a pharmacist, she completed her PhD in Pharmacy in 2014; her doctoral studies focused on neuroimaging biomarkers of treatment resistant schizophrenia. Meghan has published research articles on topics ranging from schizophrenia and bipolar disorder to drug-drug interactions. After a post-doc in California, she returned to New Zealand where she now works full-time in pharma industry and as an occasional guest lecturer at the School of Pharmacy, University of Auckland.